Skip to content

Optimer

Optimer infographic

Discover the power of Optimer® reagents – finely tuned nucleic acid affinity solutions optimized for your specific target. Whether your focus is on small molecules, proteins, or cells and…

Three factors to consider for IHC aptamers

When selecting the right IHC reagent make sure you consider these three factors and find out how IHC aptamers can help ensure success from the start. Immunohistochemistry, IHC for short,…

Anti-hapten antibody problems

Haptens are small molecules bound to a larger carrier protein to enable antibody discovery. This often yields antibodies with poor affinity and selectivity. Here we discuss why this is…

Aptamers as protein-protein interaction inhibitors

Protein-protein interactions were once considered undruggable. Our tailored aptamer selection approach is proving this isn’t so. Targets such as transcription factors, immune checkpoints in oncology, infectious disease agents, and…

The stability of aptamers

One of the key benefits of using aptamers instead of antibodies is how you store and use your reagent. Over the past 60 years the stability of oligonucleotides has…